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Abstract
Background:   WHO and UNICEF have recently developed the "Integrated Management of
Childhood Illness" (IMCI) as an efficient strategy to assist developing countries reduce childhood
mortality. Early experience with IMCI implementation suggests that clinical training is essential but
not sufficient for the success of the strategy. Attention needs to be given to strengthening health
systems, such as supervision and drug supply.
Results:  This paper presents results of evaluating an innovative approach for implementing IMCI
in Niger. It starts with strengthening district level supervision and improving the availability of child
survival drugs through cost recovery well before the beginning of IMCI clinical training. The
evaluation documented the effectiveness of the initial IMCI clinical training and referral.
Conclusions:  Strengthening supervision and assuring the availability of essential drugs need to
precede the initiation of IMCI Clinical training. Longer term follow up is necessary to confirm the
impact of the approach on IMCI preparation and implementation.
Background
In 1995, WHO and UNICEF initiated the Integrated
Management of Childhood Illness (IMCI) to assist devel-
oping countries reduce childhood mortality caused by
most childhood killer diseases: diarrhea, acute respirato-
ry infection, malaria, measles and malnutrition. IMCI
provides an efficient approach that is likely to have a
higher impact in reducing childhood mortality compared
with previous vertical disease-specific programs. The
IMCI strategy has three components: improving health
workers skills including training of first line health work-
ers; systems support including improving availability of
essential drugs, strengthening supervision and referral;
and household and community [1].
To date, IMCI has been adopted by over 60 developing
countries. Early experience with IMCI implementation
suggests that many countries have put emphasis on the
first component of the strategy without adequately
strengthening health systems needed for supporting
IMCI implementation. When health workers returned
back to their health facilities after completing IMCI clin-
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ical training they were often faced with the realities of in-
adequate drug supply and weak and infrequent technical
support through supervision [2].
This paper presents the results of the evaluation carried
out by the authors of Niger's experience in introducing
IMCI after applying interventions to strengthen supervi-
sion and improve the availability of child survival drugs
through cost recovery system. This approach was intro-
duced between 1997 and 1999 by a combined effort of
two USAID funded projects: Basic Support for Institu-
tionalizing Child Survival (BASICS) and the Quality As-
surance. The merging of the two projects in 1997 allowed
benefitting from quality assurance interventions to en-
sure the effectiveness and regularity of district supervi-
sion system and improve the availability of essential
drug supply before the beginning of IMCI clinical train-
ing.
Methods
The approach was implemented in two districts: Konni
district, in Tahoua Region, with eight health facilities,
and in Boboye district, in Dosso Region, with five health
facilities. In the beginning of 1997, quality assurance
measures were introduced to strengthen supervision at
the district level. Interventions included technical assist-
ance to revive the district supervision system and devel-
op a district level management team. The latter included
a "coach" to help primary health care staff identify and
solve problems using the local resources. District super-
vision teams received training in quality assurance in-
cluding data collection and utilization, monitoring key
health indicators, problem identification and solving
techniques such as brain storming and matrix analysis
for prioritizing identified problems and solutions [3].
The outcome of the training was a specific supervision
plan covering all health facilities in both districts. In ad-
dition, the district supervision teams participated in the
clinical IMCI training course. The project also intro-
duced two tools to increase the effectiveness of supervi-
sory visits to health facilities: 1) a Rapid Assessment
Tool, including a check list focusing on child health serv-
ices; and 2) a Supervisory Check List which is an inte-
grated list including all aspects of maternal and child
health services delivered by the health facility. In addi-
tion, limited financial support for transportation was
provided by the project to support supervision.
To improve the availability of essential drug supply, the
project provided technical assistance to support the Gov-
ernment of Niger to implement a cost recovery program.
While partial cost recovery attempts have been tried in
Boboye district since 1993, full cost recovery was intro-
duced by the government in Konni and Boboye districts
in late 1997 with the aim to fully replenish drug supply,
cover the salary of one stock keeper per health facility,
and purchase limited supplies. The project trained dis-
trict level and health facility level stock keepers in Konni
district in coordination with the European Union funded
"Pharmaciens Sans Frontiers". It involved the communi-
ty in drug supply management by selecting trusted mem-
bers of the community as stock keepers. Service fees for
cost recovery were decided at the level of health facility
with community participation. They were based mainly
on the cost of replenishing drug supplies. Fees for one
curative visit for a child under five years old were CFA
350, (USA $1= CFA 500), an amount which is equivalent
to half the average household daily income [4]. The avail-
ability of selected essential drugs was investigated before
and after the implementation of cost recovery utilizing
standard stock management indicators [5,6]
The initial IMCI clinical training for health workers in
Konni and Boboye districts took place in August and
September, 1998 using the nationally adapted guidelines
and training materials and the WHO 11-day training
course. Evaluation of the effectiveness of the initial IMCI
training included: 1) direct observation of health workers
while examining a limited number of children under five
years utilizing the IMCI guidelines and 2) a review of 269
IMCI forms filled in September and October, 1998 for
children 2–60 months of age by trained health workers
in six health facilities in the two districts.
Results
1. Improving district-level supervision
For years before the intervention, no supervisory visits
had been conducted from district level supervisors to the
health facility level for any of the 13 health facilities in
both districts. Beginning 1998, after the intervention, the
district supervision teams in both Konni and Boboye dis-
tricts carried out all scheduled supervisory visits on time.
Each health facility in each district was visited four times
a year. The supervisory visits were carried out utilizing
the two supervisory tools. However, interviewed staff
mentioned that the supervisory check list, while compre-
hensive, was too long. Supervisors explained to health fa-
cility staff and recorded their findings on a special health
facility register for follow up and action. Problem solving
techniques, particularly brain storming for prioritizing
problems and matrix analyses for selecting feasible solu-
tions were well understood and utilized in all health fa-
cilities in the two districts. The cost of conducting one
supervisory visit was calculated to be $29, including per
diem and transportation cost from district to the health
facility and back.BMC International Health and Human Rights (2001) 1:1 http://www.biomedcentral.com/1472-698X/1/1
2. Improving the availability of child survival drugs through 
cost recovery
The cost recovery system succeeded in eliminating the
chronic state of lack of essential drugs that existed before
the implementation of the system. Examination of the
stock of selected child survival drugs in Konni and
Boboye districts revealed that cost recovery has resulted
in fewer stock-outs, shorter duration of stock-outs and
higher average monthly consumption, an indication of
the general availability of drugs. An exception has been
observed in Boboye district where there was a four
month long stock-out of cotrimoxazole after cost recov-
ery. This was due to an overall shortage at the central
store level. Stock keepers in Konni district, who received
stock management training, were able to spare their dis-
trict such a long stock-out by wisely keeping a safety
stock (Table 1).
In spite the success of cost recovery in increasing the
availability of essential drugs, there was an associated
drop in the health facility utilization rate. Data from both
Konni and Boboye districts revealed a drop in the
number of out-patient visits beginning 1998, after the in-
troduction of cost recovery. In the first half of 1998, new
curative visits for children less than five years dropped
by 33% and 22% of their 1997 levels in Konni and Boboye
districts respectively. Such a drop in the number of
health facility visits did not only affect curative visits but
also preventive visits such as neonatal visits, where im-
munization is initiated, and antenatal visits, where teta-
nus toxoid is administered along with other antenatal
services (Figure 1). At one health facility in Konni dis-
trict, Badaguichiri, where data were available to monitor
out patient visits for a longer period of time, the utiliza-
tion rate started to show a strong recovery in the third
quarter of 1998. The rise did not quite bring the utiliza-
tion rate to the pre-cost recovery level, yet it brought it
almost to the same level of another comparable health fa-
cility which had not yet introduced cost recovery (Figure
2).
3. Effectiveness of the initial IMCI clinical training
An evaluation of the effectiveness of the initial IMCI clin-
ical training revealed that trained health workers, in gen-
eral, were capable of examining children using the
adapted IMCI standards. However, 6% of the examined
forms failed to indicate whether the visit was an initial or
Table 1: Stock situation for selected IMCI essential drugs before(1997) and after (1998) cost recovery
Cotrimoxazole Chloroquine ORS Packets
480 mg 100 mg
Stock Management Indicator (Box of 1000 tablets) (Box of 1000 tablets)
Before After Before After Before After
(1997) (1998) (1997) (1998) (1997) (1998)
Konni District:
N u m b e r  o f  S t o c k o u t s 113020
Duration of Stockouts 3 months 1 month 19 days 0 10 months 0
Average Monthly Consumption 19.6 boxes 39.4 boxes 20.1 boxes 56.4 boxes 84 packets 1455 packets
Boboye District:
N u m b e r  o f  S t o c k o u t s 011110
Duration of Stockouts 0 4 months 4 months 2 months 1.5 months 0
Average Monthly Consumption 33.1 boxes 14.2 boxes 29 boxes 60.1 boxes 400 packets 572 packets
Figure 1
Number of Visits to Primary Health Facilities in Boboye Dis-
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follow-up visit. Furthermore, the nutrition section was
not completed in 21% of forms. These findings suggest
that health workers need to pay more attention to cor-
rectly filling out the IMCI forms and in assuring that the
nutritional status of all children is checked and noted.
The future monitoring of the same indicators can help in
assessing the effectiveness of the supervision system to
improve health workers' accuracy in completing IMCI
forms and assessing the children's nutritional status (Ta-
ble 2).
The IMCI standards for referral of very sick children and
for follow up visits were largely ignored. Only six (23%)
of children with a general danger sign were actually re-
ferred by health facility staff. Four of them were referred
to a private hospital in Konni district (Galmi Hospital).
Out of a total of 182 follow-up visits required, only 11
(6%) actually returned to the health facility for follow up.
Of children who had their nutritional status checked
(212), 21% and 34% suffered from low weight for age and
anaemia respectively (Table 2). Health workers who
were interviewed mentioned that finding adequate time
to counsel care takers about the nutrition of their chil-
dren is a major limitation.
Discussion
Niger's approach in applying quality assurance measures
at district level succeeded in better preparing the target
districts before the implementation of IMCI clinical
guidelines at the health facility level. Improvements in
supervision and availability of drug supply were docu-
mented. Exposing district supervisors to two types of
training, quality assurance and clinical IMCI, was impor-
tant in qualifying supervisors to support IMCI imple-
mentation. However, longer term follow up is necessary
to confirm the long term impact of applying quality as-
surance measures to better prepare of IMCI implemen-
tation. In addition, the intervention included external
financial support to revive district-level supervision. To
sustain the achieved improvement, this cost needs to be
transferred gradually to the district's health budget.
Since the project has provided financial support to revive
district level supervision, to sustain the achieved success,
it is important that the cost of conducting supervision be
transferred gradually to the district's health budget.
Community involvement in cost recovery through partic-
ipation in determining cost for service and in managing
drug stock was key in assuring community's acceptance
and trust in the system. Cost recovery was more effective
when combined with stock management training. In
Konni district, where cost recovery was combined with
stock management training, results for improving avail-
ability of essential drugs were better than in Boboye,
where such training was not conducted.
The observed drop in the number of outpatient visits in-
duced by cost recovery is of particular importance, since
the impact of IMCI is related to its ability to minimize
missed opportunities of preventive and curative care at
the outpatient level. Experience with cost recovery in
other countries suggest that such a drop could be tempo-
rary [7]. The strong recovery of outpatient visits in
Badaguichiri health facility during the third quarter of
1998 could be a sign for the beginning of the reverse in
the outpatient trend. Other factors, such as the rainy sea-
son in June to October and the harvest around the third
quarter, could have contributed to the fluctuation in the
number of outpatient visits. Longer monitoring of the
level of health facility utilization is needed to fully under-
stand the effect of cost recovery on health service utiliza-
tion.
The observed difficulty in complying with IMCI stand-
ards for referral and follow-up visits presents a challenge
not only to health authorities in Niger but also to the
IMCI standards themselves. The current IMCI referral
and follow up standards may not be suitable for a coun-
try like Niger with such a widely dispersed population
and only 30% of the population living within five kilom-
eters of a health facility. Health facility staff mentioned
that referral was not feasible because of the lack of trans-
portation and the long distance between health facilities
and the district level hospital. The distance between
health facilities and the district hospital ranged from 25
– 85 km. In addition, district level hospitals in both Kon-
Figure 2
Number of New Curative Visits at Two Health Facilities
With & Without Cost Recovery by Quarter (Q) in 1997 &
1998BMC International Health and Human Rights (2001) 1:1 http://www.biomedcentral.com/1472-698X/1/1
ni and Boboye were not well equipped to deal with very
sick children which further discouraged both health
workers at the health facility level and mothers to use
them as a referral site. Referral sites need to be included
in future IMCI programs.
Conclusions
In Niger, quality assurance measures to strengthen su-
pervision and improve the availability of child survival
drugs resulted in better preparation of the target districts
for IMCI. Both the frequency and the effectiveness of su-
pervisory visits improved. Cost recovery combined with
drug supply stock management resulted in improving
the availability of child survival drugs. Community par-
ticipation in managing cost recovery was key in assuring
acceptance and trust in the system. However, cost recov-
ery induced an initial drop in the number of outpatient
visits which requires longer monitoring. Health workers
trained in IMCI were capable of examining children us-
ing the IMCI guidelines and in identifying very sick chil-
dren. However, compliance to the guidelines standards
for referral and follow-up visits was weak due to the wide
dispersed nature of Niger's population, large distance
between health facilities and referral sites, and lack of
transportation.
Niger's experience suggests that it is important to
strengthen the supervision system at the district level
and assure the availability of essential drugs before the
implementation of IMCI. However, due to the short du-
ration between the initial IMCI clinical training and this
evaluation, longer term follow up is necessary to confirm
the impact of such quality assurance measures on the im-
plementation of IMCI. The evaluation also revealed that
while IMCI clinical guidelines are understood and fol-
lowed by primary health care workers, standards for re-
ferral should consider the particular country situation.
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Table 2: Observations on IMCI forms filled during September & October 98 for children 2–60 months old in six primary health facilities* 
in Konni and Boboye districts
Observation/Indicator Konni Boboye
District District Total
no. (%) no. (%) no. (%)
Number of examined forms 142 127 269
Forms marked for initial or follow-up visits 134 (94) 118 (93) 252 (94)
Children with a general danger sign 15 (11) 11 (9) 26 (10)
Referred children with a general danger sign 5 (33) 1 (11) 6 (23)
5/15 1/11 6/26
Forms with the nutrition section completed 100 (70) 112 (88) 212 (79)
Children with low weight for age 33 (33) 11 (11) 44 (21)
33/100 11/112 44/212
Children with severe or mild anaemia 44 (44) 29 (26) 73 (34)
44/100 29/112 73/212
Forms with follow up visits required 92 (65) 90 (71) 182 (68)
Follow-up visits conducted 0 (0) 11 (12) 11 (6)
11/90 11/182
* Health facilities: Malbaza, Yaya & Dougueraoua in Konni Distirct and Fabidgi, Falmey & Tonkossarey in Boboye District.BMC International Health and Human Rights (2001) 1:1 http://www.biomedcentral.com/1472-698X/1/1
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